About 85–95% of GIST harbour oncogenic mutations affecting KIT or PDGFRA, two highly homologues cell surface tyrosine kinase receptors for stem cells and platelet-derived growth factor. This evidence concerns the gene NTRK1 and gastrointestinal stromal tumor.